SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go?
PFE 25.65-0.9%Jan 16 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: TradeOfTheDay who wrote ()11/29/1997 9:53:00 AM
From: Rob Loney  Read Replies (2) of 9523
 
Pfizer take over by Glaxo not possible for many reasons.

1) Pfizer is too big
2) Pfizer has co-marketing deals with Parke-Davis and other companies
that are very profitable and would be lost if bought out.

This year Parke-Davis was the Phamaceutical Company of the year.

Next year my call is either Pfizer or Roche.

Pfizer is making buckets of money on Lipitor, Norvasc, Zithromax,
and will launch a new oral for errectile dysfunction and a new
broad spectrum antibiotic that looks real promissing (trovafloxin).

If you don't own Pfizer, pick some up.

It'll be great in '98
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News